【ChiCTR2000028788】Does the anterolateral ligament status have an effect on the preference of anterior cruciate ligament reconstruction in the patients with partial anterior cruciate ligament tears?
ChiCTR2000028788
结束
/
/
/
2020-01-04
/
/
anterior cruciate ligament rupture
Does the anterolateral ligament status have an effect on the preference of anterior cruciate ligament reconstruction in the patients with partial anterior cruciate ligament tears?
Does the anterolateral ligament status have an effect on the preference of anterior cruciate ligament reconstruction in the patients with partial anterior cruciate ligament tears?
73200
ACL tears are divided into two as total and partial. There is no consensus on the criteria for the diagnosis of a partial ACL tear [1]. Although partial tears are defined as one of the anteromedial (AM) and posterolateral (PL) bundles being intact and the other being ruptured, they are also defined as the continuity of some of the tendons between the femoral and tibial attachment of the ACL [2]. Among all ACL tears, the rate of partial ACL tears was found as 10-35% [3]. The continuation of rotational instability in some patients after ACL reconstruction suggested that additional support structures are effective in stability. In later studies, it was shown that the anterolateral ligament (ALL) also contributes to stability together with the ACL of the knee [3-7]. The study aimed to retrospectively determine the effect of ALL status, whether intact or ruptured, on the choice of treatment in patients with partial ACL tears.
横断面
回顾性研究
N/A
N/A
No
/
32;28
/
2016-12-24
2019-10-31
/
Following the orthopedic examinations and magnetic resonance imaging (MRI) performed between 2016 and 2018, a total of 120 patients with suspected partial ACL tears and with meniscal and cartilage lesions requiring arthroscopic knee surgery were identified. After examining the ALLs of these patients using MRI, 60 patients who were diagnosable and had sufficient follow-up were included in the study retrospectively.;
请登录查看The patients who are not diagnosable for ALL status using MRI, with total ACL tears in MRI, and at the same time with physical examination findings suggestive of total ACL tears were excluded from the study. Patients with a follow-up of less than one year were excluded from the study.;
请登录查看namik kemal health application & research center
/
namik kemal health application & research center的其他临床试验
- Evaluation of IL10 and TGF-beta levels in blood as a biomarker of peri-prosthetic joint infection
- Does the anterolateral ligament status have an effect on the preference of anterior cruciate ligament reconstruction in the patients with partial anterior cruciate ligament tears?
- Is cyclic exercise performed effective on grafts during ACL reconstruction?
土耳其锡尔纳克州立医院的其他临床试验
- Minimally invasive hook-assisted reduction and cephalomedullary nailing for intertrochanteric femur fractures
- Evaluation of IL10 and TGF-beta levels in blood as a biomarker of peri-prosthetic joint infection
- Does the anterolateral ligament status have an effect on the preference of anterior cruciate ligament reconstruction in the patients with partial anterior cruciate ligament tears?
- Is cyclic exercise performed effective on grafts during ACL reconstruction?
- Procedural outcomes of double vs. single fluoroscopy for fixing supracondylar humerus fractures in children
最新临床资讯
-
一项5年临床安全随访研究启示:#脐带间充质干细胞(#hUC-MSCs)
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点,索弗度肽(survodutide)成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 62
-
摩熵咨询 20 3
-
颁布机构:国家卫生健康委办公厅、 2026-11-10
-
颁布机构:国家卫健委(原国家卫计委) 2026-11-10
-
颁布机构:国家药品审评中心(CDE) 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构:国家市场监督管理总局 2026-11-07
-
颁布机构:国家市场监督管理总局 2026-11-07
-
颁布机构:国家市场监督管理总局 2026-11-04

